These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 38646136

  • 1. Cervical precancerous and cancerous lesions screening using Pap smear test at Provincial Referral Hospital of Bukavu, Eastern DR Congo: profile and recommendations to stakeholders.
    Mayeri DG, Kahasha PM, Kibalama IB, Mongane J, Louguè M, Birindwa EK, Mwimangire SC, Kikuru CK, Materanya JM, Bisimwa YK, Kasago B, Mukengeshai LM.
    Pan Afr Med J; 2024; 47():57. PubMed ID: 38646136
    [Abstract] [Full Text] [Related]

  • 2. Prevalence of cervical cancer and pre-cancerous lesions among unscreened Women in Kumasi, Ghana.
    Donkoh ET, Agyemang-Yeboah F, Asmah RH, Wiredu EK.
    Medicine (Baltimore); 2019 Mar; 98(13):e14600. PubMed ID: 30921178
    [Abstract] [Full Text] [Related]

  • 3. Comparison of conventional and liquid-based Pap smear methods in the diagnosis of precancerous cervical lesions.
    Honarvar Z, Zarisfi Z, Salari Sedigh S, Masoumi Shahrbabak M.
    J Obstet Gynaecol; 2022 Aug; 42(6):2320-2324. PubMed ID: 35579303
    [Abstract] [Full Text] [Related]

  • 4. Prevalence and Risk Assessment of Cervical Cancer Screening by Papanicolaou Smear and Visual Inspection with Acetic Acid for Pregnant Women at a Thai Provincial Hospital.
    Lertcharernrit J, Sananpanichkul P, Suknikhom W, Bhamarapravatana K, Suwannarurk K, Leaungsomnapa Y.
    Asian Pac J Cancer Prev; 2016 Aug; 17(8):4163-7. PubMed ID: 27644678
    [Abstract] [Full Text] [Related]

  • 5. Three-year risk of high-grade CIN for women aged 30 years or older who undergo baseline Pap cytology and HPV co-screening.
    Guo M, Khanna A, Wang J, Dawlett MA, Kologinczak TL, Lyons GR, Bassett RL, Sneige N, Gong Y, Bevers TB.
    Cancer Cytopathol; 2017 Aug; 125(8):644-651. PubMed ID: 28498639
    [Abstract] [Full Text] [Related]

  • 6. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014-2016.
    Ouh YT, Min KJ, Cho HW, Ki M, Oh JK, Shin SY, Hong JH, Lee JK.
    J Gynecol Oncol; 2018 Jan; 29(1):e14. PubMed ID: 29185272
    [Abstract] [Full Text] [Related]

  • 7. Molecular Pap smear: HPV genotype and DNA methylation of ADCY8, CDH8, and ZNF582 as an integrated biomarker for high-grade cervical cytology.
    Shen-Gunther J, Wang CM, Poage GM, Lin CL, Perez L, Banks NA, Huang TH.
    Clin Epigenetics; 2016 Jan; 8(1):96. PubMed ID: 27651839
    [Abstract] [Full Text] [Related]

  • 8. The prevalence and course of preinvasive cervical lesions during pregnancy in a Northern Nigerian Teaching Hospital.
    Bakari F, Abdul MA, Ahmed SA.
    Ann Afr Med; 2017 Jan; 16(2):74-80. PubMed ID: 28469121
    [Abstract] [Full Text] [Related]

  • 9. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
    Latsuzbaia A, Hebette G, Fischer M, Arbyn M, Weyers S, Vielh P, Schmitt F, Mossong J.
    Diagn Cytopathol; 2017 May; 45(5):384-390. PubMed ID: 28247516
    [Abstract] [Full Text] [Related]

  • 10. Cervical cancer screening by cytology and the burden of epithelial abnormalities in low resource settings: a tertiary-center 42-year study.
    Ezzelarab S, El-Husseiny A, Nasreldin M, Ali R, Nabhan A, Early Cervical Cancer Detection Consortium.
    BMC Womens Health; 2024 Jul 17; 24(1):405. PubMed ID: 39020330
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. HPV detection rates and histopathologic follow-up of patients with HSIL cytology in a large academic women's hospital laboratory.
    Ashman D, Zhang H, Li J, Austin M, Wang T, Pradhan D, Zhao C.
    J Am Soc Cytopathol; 2020 Jul 17; 9(6):550-555. PubMed ID: 32475726
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Benefit and burden in the Dutch cytology-based vs high-risk human papillomavirus-based cervical cancer screening program.
    Loopik DL, Koenjer LM, Siebers AG, Melchers WJG, Bekkers RLM.
    Am J Obstet Gynecol; 2021 Feb 17; 224(2):200.e1-200.e9. PubMed ID: 32800820
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.